Clinic
Springfield Urgent Care, P.L.L.C.
Springfield Urgent Care, P.L.L.C. was paid $3.63M by Medicaid between Mar 2018 and Dec 2024, across 54 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoSPRINGFIELD URGENT CARE, P.L.L.C.
CLARKSTON, MI 48348
CLARKSTON, MI 48348
33aNPI1144747460assigned 08/28/2017
33bProvider typeUrgent Care Clinic/Center
28Total paid$3.63M
24GClaims107,891
24DCodes billed54
24AFirst – last monthMar 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#19 of 239
Median peer was paid$346K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 945 | $57K | |
| 2019 | 2,789 | $140K | |
| 2020 | 5,105 | $240K | |
| 2021 | 10,932 | $507K | |
| 2022 | 21,789 | $685K | |
| 2023 | 33,467 | $921K | |
| 2024incomplete | 32,864 | $1.08M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 14,111 | 13,321 | $1.02M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 13,360 | 12,588 | $719K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 20% | 7,809 | 7,789 | $710K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15% | 8,296 | 8,275 | $529K |
| 99058 | 5.4% | 4,869 | 4,498 | $197K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 3.1% | 3,951 | 3,862 | $114K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.1% | 6,340 | 6,223 | $75K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 4,990 | 2,530 | $55K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 609 | 609 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,797 | 2,726 | $25K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 235 | 232 | $23K |
| 99051 | <1% | 8,753 | 8,429 | $19K |
42 more codes
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 17,840 | $16K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 827 | $13K |
| 99205 | Prolong outpt/office vis | <1% | 107 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 213 | $9K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 216 | $8K |
| 73630 | <1% | 429 | $7K | |
| 73610 | <1% | 373 | $7K | |
| 81025 | <1% | 1,003 | $6K | |
| 73130 | <1% | 290 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 141 | $4K |
| 81003 | <1% | 2,668 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 655 | $4K |
| 87807 | <1% | 292 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,689 | $2K |
| 73110 | <1% | 104 | $2K | |
| 93000 | <1% | 243 | $2K | |
| S9083 | Global fee urgent care centers | <1% | 90 | $2K |
| 73562 | <1% | 60 | $1K | |
| 99000 | <1% | 1,858 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,091 | $1K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 16 | $944.80 |
| 36415 | Collection of venous blood by venipuncture | <1% | 396 | $780.60 |
| 0012A | <1% | 19 | $654.20 | |
| 73140 | <1% | 27 | $642.12 | |
| 12001 | <1% | 12 | $616.07 | |
| 0011A | <1% | 16 | $538.50 | |
| 29125 | <1% | 12 | $380.40 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 505 | $366.60 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 57 | $299.71 |
| 69209 | <1% | 42 | $220.10 | |
| 86308 | <1% | 54 | $210.60 | |
| 74018 | <1% | 12 | $194.04 | |
| 90714 | <1% | 13 | $184.10 | |
| 87280 | <1% | 32 | $166.65 | |
| 87905 | <1% | 19 | $101.20 | |
| 90688 | <1% | 12 | $71.36 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 56 | $56.27 |
| 82962 | <1% | 12 | $31.39 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 12 | $8.44 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 111 | $5.74 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 88 | $4.12 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 59 | $3.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGARDNER, TRESSA (DO/OWNER)